Laura Lombardero - Publications

2009-2015 Pharmacology Univ P Vasco, Leioa, Euskadi, Spain 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Davis N, Mota BC, Stead L, Palmer EOC, Lombardero L, Rodríguez-Puertas R, de Paola V, Barnes SJ, Sastre M. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease. Journal of Neuroinflammation. 18: 73. PMID 33731156 DOI: 10.1186/s12974-021-02117-y  0.4
2018 Llorente-Ovejero A, Manuel I, Lombardero L, Giralt MT, Ledent C, Giménez-Llort L, Rodríguez-Puertas R. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29865071 DOI: 10.3233/JAD-180137  0.4
2016 Manuel I, Lombardero L, Laferla FM, Giménez-Llort L, Rodríguez-Puertas R. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. Neuroscience. PMID 27223629 DOI: 10.1016/j.neuroscience.2016.05.012  0.4
2015 Barreda-Gómez G, Lombardero L, Giralt MT, Manuel I, Rodríguez-Puertas R. Effects of galanin subchronic treatment on memory and muscarinic receptors. Neuroscience. 293: 23-34. PMID 25732139 DOI: 10.1016/j.neuroscience.2015.02.039  0.4
Show low-probability matches.